Correction to: Hepatic arterial infusion chemotherapy (HAIC) combined with Tislelizumab and Lenvatinib for unresectable hepatocellular carcinoma: a retrospective single-arm study

Cell Oncol (Dordr). 2024 Dec;47(6):2277-2278. doi: 10.1007/s13402-024-01031-8.

Authors

Ruirui Sun¹, Yang Gou¹, Long Pan¹, Qiang He¹, Yin Zhou², Yi Luo¹, Chenrui Wu¹, Yaowu Zhao¹, Zixuan Fu¹, Ping Huang³

Affiliations

¹ Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400000, China.
² Department of Radiography, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400000, China.
³ Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400000, China. huangping4069@163.com.

PMID: 39718739
DOI: 10.1007/s13402-024-01031-8

No abstract available

Publication types

Published Erratum